These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 21374660)

  • 21. Dynamic FDG-PET is useful for detection of cholangiocarcinoma in patients with PSC listed for liver transplantation.
    Prytz H; Keiding S; Björnsson E; Broomé U; Almer S; Castedal M; Munk OL;
    Hepatology; 2006 Dec; 44(6):1572-80. PubMed ID: 17133469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
    Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
    J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characteristics and clinical course of primary sclerosing cholangitis in France: a prospective cohort study.
    Garioud A; Seksik P; Chrétien Y; Corphechot C; Poupon R; Poupon RE; Chazouillères O
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):842-7. PubMed ID: 19779305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cholangiocarcinoma in primary sclerosing cholangitis: "chronicle of a death foretold"?].
    Margalit M; Elinav H; Goldin E; Ilan Y
    Harefuah; 2003 Jun; 142(6):421-5, 486. PubMed ID: 12858825
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary sclerosing cholangitis and cholangiocarcinoma.
    Lazaridis KN; Gores GJ
    Semin Liver Dis; 2006 Feb; 26(1):42-51. PubMed ID: 16496232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance cholangiopancreatography in the diagnosis of primary sclerosing cholangitis.
    Weber C; Kuhlencordt R; Grotelueschen R; Wedegaertner U; Ang TL; Adam G; Soehendra N; Seitz U
    Endoscopy; 2008 Sep; 40(9):739-45. PubMed ID: 18698533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum Metabolites as Diagnostic Biomarkers for Cholangiocarcinoma, Hepatocellular Carcinoma, and Primary Sclerosing Cholangitis.
    Banales JM; Iñarrairaegui M; Arbelaiz A; Milkiewicz P; Muntané J; Muñoz-Bellvis L; La Casta A; Gonzalez LM; Arretxe E; Alonso C; Martínez-Arranz I; Lapitz A; Santos-Laso A; Avila MA; Martínez-Chantar ML; Bujanda L; Marin JJG; Sangro B; Macias RIR
    Hepatology; 2019 Aug; 70(2):547-562. PubMed ID: 30325540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors and clinical presentation of hepatobiliary carcinoma in patients with primary sclerosing cholangitis: a case-control study.
    Bergquist A; Glaumann H; Persson B; Broomé U
    Hepatology; 1998 Feb; 27(2):311-6. PubMed ID: 9462625
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Duodenal EUS to identify thickening of the extrahepatic biliary tree wall in primary sclerosing cholangitis.
    Mesenas S; Vu C; Doig L; Meenan J
    Gastrointest Endosc; 2006 Mar; 63(3):403-8. PubMed ID: 16500387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MicroRNAs in Serum and Bile of Patients with Primary Sclerosing Cholangitis and/or Cholangiocarcinoma.
    Voigtländer T; Gupta SK; Thum S; Fendrich J; Manns MP; Lankisch TO; Thum T
    PLoS One; 2015; 10(10):e0139305. PubMed ID: 26431155
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease.
    Novotný I; Dítě P; Trna J; Lata J; Husová L; Geryk E
    Dig Dis; 2012; 30(2):216-9. PubMed ID: 22722442
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma].
    Wu YM; Johlin FC; Rayhill SC; Jensen CS; Jin X; Mitros FA
    Zhonghua Wai Ke Za Zhi; 2009 Aug; 47(15):1155-61. PubMed ID: 20021907
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic performance of imaging criteria for distinguishing autoimmune cholangiopathy from primary sclerosing cholangitis and bile duct malignancy.
    Gardner CS; Bashir MR; Marin D; Nelson RC; Choudhury KR; Ho LM
    Abdom Imaging; 2015 Oct; 40(8):3052-61. PubMed ID: 26350286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term, tumor-free survival after radiotherapy combining hepatectomy-Whipple en bloc and orthotopic liver transplantation for early-stage hilar cholangiocarcinoma.
    Wu Y; Johlin FC; Rayhill SC; Jensen CS; Xie J; Cohen MB; Mitros FA
    Liver Transpl; 2008 Mar; 14(3):279-86. PubMed ID: 18306329
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biliary carcinoembryonic antigen levels are a marker for cholangiocarcinoma.
    Nakeeb A; Lipsett PA; Lillemoe KD; Fox-Talbot MK; Coleman J; Cameron JL; Pitt HA
    Am J Surg; 1996 Jan; 171(1):147-52; discussion 152-3. PubMed ID: 8554130
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic benefit of biliary brush cytology in cholangiocarcinoma in primary sclerosing cholangitis.
    Boberg KM; Jebsen P; Clausen OP; Foss A; Aabakken L; Schrumpf E
    J Hepatol; 2006 Oct; 45(4):568-74. PubMed ID: 16879890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biliary diseases - new insights and developments].
    Weismüller TJ; Lankisch TO
    Dtsch Med Wochenschr; 2011 Apr; 136(14):713-6. PubMed ID: 21448834
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study.
    Chalasani N; Baluyut A; Ismail A; Zaman A; Sood G; Ghalib R; McCashland TM; Reddy KR; Zervos X; Anbari MA; Hoen H
    Hepatology; 2000 Jan; 31(1):7-11. PubMed ID: 10613720
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differences in phosphatidylcholine and bile acids in bile from Egyptian and UK patients with and without cholangiocarcinoma.
    Hashim Abdalla MS; Taylor-Robinson SD; Sharif AW; Williams HR; Crossey MM; Badra GA; Thillainayagam AV; Bansi DS; Thomas HC; Waked IA; Khan SA
    HPB (Oxford); 2011 Jun; 13(6):385-90. PubMed ID: 21609370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin.
    Voigtländer T; Metzger J; Schönemeier B; Jäger M; Mischak H; Manns MP; Lankisch TO
    United European Gastroenterol J; 2017 Aug; 5(5):668-676. PubMed ID: 28815030
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.